Lmcg Investments LLC Sells 489 Shares of Inspire Medical Systems, Inc. (NYSE:INSP)

Lmcg Investments LLC decreased its position in Inspire Medical Systems, Inc. (NYSE:INSP) by 1.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,609 shares of the company’s stock after selling 489 shares during the period. Lmcg Investments LLC owned approximately 0.10% of Inspire Medical Systems worth $6,460,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Russell Investments Group Ltd. boosted its stake in Inspire Medical Systems by 98.9% in the 1st quarter. Russell Investments Group Ltd. now owns 31,933 shares of the company’s stock worth $6,859,000 after purchasing an additional 15,877 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its stake in Inspire Medical Systems by 51.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 459,766 shares of the company’s stock valued at $98,754,000 after acquiring an additional 156,893 shares during the period. Tidal Investments LLC bought a new position in Inspire Medical Systems during the 1st quarter valued at about $1,151,000. AQR Capital Management LLC lifted its stake in Inspire Medical Systems by 152.7% during the 2nd quarter. AQR Capital Management LLC now owns 231,845 shares of the company’s stock valued at $31,028,000 after acquiring an additional 140,090 shares during the period. Finally, Teachers Retirement System of The State of Kentucky lifted its stake in Inspire Medical Systems by 27.1% during the 1st quarter. Teachers Retirement System of The State of Kentucky now owns 40,501 shares of the company’s stock valued at $8,699,000 after acquiring an additional 8,625 shares during the period. Institutional investors own 94.91% of the company’s stock.

Inspire Medical Systems Trading Down 2.2 %

Inspire Medical Systems stock traded down $4.33 during midday trading on Friday, hitting $190.71. The stock had a trading volume of 747,953 shares, compared to its average volume of 594,146. The firm’s fifty day moving average is $201.08 and its two-hundred day moving average is $181.00. The company has a market capitalization of $5.69 billion, a PE ratio of 1,059.28 and a beta of 1.34. Inspire Medical Systems, Inc. has a 52-week low of $123.00 and a 52-week high of $257.40.

Inspire Medical Systems (NYSE:INSP) last released its earnings results on Tuesday, August 6th. The company reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.46. Inspire Medical Systems had a net margin of 0.85% and a return on equity of 1.03%. The company had revenue of $195.89 million during the quarter, compared to analyst estimates of $189.08 million. During the same period in the prior year, the firm posted ($0.41) EPS. The firm’s quarterly revenue was up 29.6% compared to the same quarter last year. As a group, equities research analysts predict that Inspire Medical Systems, Inc. will post 0.75 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms have issued reports on INSP. Truist Financial restated a “buy” rating and set a $240.00 target price (up previously from $217.00) on shares of Inspire Medical Systems in a research note on Monday, September 30th. Leerink Partners upped their price target on shares of Inspire Medical Systems from $167.00 to $197.00 and gave the company a “market perform” rating in a research report on Tuesday, September 10th. KeyCorp reduced their price target on shares of Inspire Medical Systems from $278.00 to $236.00 and set an “overweight” rating for the company in a research report on Wednesday, August 7th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $260.00 price target on shares of Inspire Medical Systems in a research report on Wednesday, August 7th. Finally, Morgan Stanley reduced their price target on shares of Inspire Medical Systems from $250.00 to $210.00 and set an “overweight” rating for the company in a research report on Monday, July 15th. Four analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $219.58.

Insiders Place Their Bets

In other Inspire Medical Systems news, Director Shawn Mccormick sold 800 shares of the company’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $220.00, for a total value of $176,000.00. Following the completion of the transaction, the director now directly owns 23,140 shares in the company, valued at $5,090,800. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, Director Shawn Mccormick sold 800 shares of the stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $220.00, for a total transaction of $176,000.00. Following the completion of the transaction, the director now directly owns 23,140 shares in the company, valued at approximately $5,090,800. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Randy Ban sold 4,861 shares of the stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $188.55, for a total value of $916,541.55. Following the transaction, the insider now owns 3,056 shares of the company’s stock, valued at $576,208.80. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 5,692 shares of company stock worth $1,099,207 in the last three months. 4.10% of the stock is owned by company insiders.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.